Suzuki, Fumitaka http://orcid.org/0000-0001-5232-796X
Hosaka, Tetsuya
Suzuki, Yoshiyuki
Sezaki, Hitomi
Akuta, Norio
Fujiyama, Shunichiro
Kawamura, Yusuke
Saitoh, Satoshi
Arase, Yasuji
Kobayashi, Mariko
Kumada, Hiromitsu
Funding for this research was provided by:
Program for Basic and Clinical Research on Hepatitis, Japan Agency for Medical Research and Development (JP23fk0210084)
Okinaka Memorial Institute for Medical Research
Article History
Received: 26 July 2023
Accepted: 20 September 2023
First Online: 14 October 2023
Declarations
:
: Suzuki F has received lecture fees from Gilead Sciences Inc. Hosaka has received lecture fees from Gilead Sciences Inc. Akuta has received lecture fees from Abbvie GK. Kawamura has received lecture fees from Eisai Co., Ltd. Kumada has received investigator, lecture and consulting fees from Gilead Sciences Inc., Abbvie GK, Eisai Co., Ltd, Chugai Pharmaceutical Co., Ltd., and Sumitomo Dainippon Pharma Co., Ltd. The other authors declare that they have no conflict of interest.